NCT00060684 - Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

May 31, 2007

Conditions

Lymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, FollicularLymphoma, Small Cleaved-Cell, Follicular

Interventions

DRUG

Pixantrone (BBR 2778)

DRUG

fludarabine

DRUG

dexamethasone

DRUG

rituximab

Trial Locations (4)

Greater Baltimore Medical Center, Baltimore

MD Anderson Cancer Center, Houston

Arizona Clinical Research Center, Tucson

New Mexico Onc/Hem Consultants, Inc., Albuquerque